Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro

Blood

Volumn 89, Issue 6, 1997, Pages 1862-1869

  Mirza, Amer M ^a   Ezzat, Shereen ^a   Axelrad, Arthur A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; POLYCYTHEMIA VERA; PRIORITY JOURNAL;

EID: 0030946391     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.1862     Document Type: Article

References (33)

1. Bethard WF, Jacobson LO: Definition and classification of polycythemia, in Klein H (ed): Polycythemia: Theory and Mahagement. Springfield, IL, Charles C. Thomas, 1973, p 18
2. de Klerk G, Rosengarten PC, Vet RJ, Goudsmit R: Serum erythropoietin (ESF) titer in polycythemia. Blood 58:1171, 1981
3. Correa PN, Axelrad AA: Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: Role of insulin-like growth factor I. Blood 78:2823, 1991
4. Correa PN, Eskinazi D, Axelrad AA: Circulating erythroid progenitors in Polycythemia vera are hypersensitive to insulin-like growth factor I in vitro: Studies in an improved serum-free medium. Blood 83:99, 1994
5. Mirza AM, Correa PN, Axelrad AA: Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor b subunit in circulating mononuclear cells of patients with polycythemia vera. Blood 86:877, 1995
6. Daughaday WH, Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 10:68, 1989
7. Cohick WS, Clemmons DR: The insulin-like growth factors. Annu Rev Physiol 55:131, 1993
8. Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y: Measurement of free insulin-like growth factor-I using immunoradiometric assay. J Immunoassay 15:263, 1994
9. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3, 1995
10. Schmid C, Rutishauser J, Schlapfer I, Froesch ER, Zapf J: Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF-I-induced stimulation of osteoblasts: Control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochem Biophys Res Commun 179:579, 1991
11. Liu L, Delbe J, Blat C, Zapf J, Harel L: Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II. J Cell Physiol 153:15, 1992
12. Okajima T, Iwashita M, Takeda Y, Sakamoto S, Tanabe T, Yasuda T, Rosenfeld RG: Inhibitory effects of insulin-like growth factor (IGF)-binding proteins-1 and -3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts. J Endocrinol 136:457, 1993
13. Lee PDK, Conover CA, Powell DR: Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204:4, 1993
14. Elgin RG, Busby WHJ, Clemmons DR. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254, 1987
15. Campbell PG, Novak JF: Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells. J Cell Physiol 149:293, 1991
16. Burch WM, Correa J, Shaveley JE, Powell DR: The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I mediated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab 70:173, 1990
17. Berlin NI: Diagnosis and classification of the polycythemias. Semin Hematol 12:339, 1975
18. Ezzat S, Song-Guang R, Braunstein GD, Melmed S: Octreotide stimulates insulin-like growth factor binding protein-1 : A potential pituitary-independent mechanism for drug action. J Clin Endocrinol Metab 75:1459, 1992
19. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M: Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138, 1986
20. Yki-jarvinen H, MakimattilaS, Utriainen T, Rutanen E: Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 80:3227, 1995
21. Busby WHJ, Klapper DG, Clemmons DR: Purification of a 31,000 dalton insulin-like growth factor binding protein from human amniotic fluid: Isolation of two isoforms with different biologic actions. J Biol Chem 263:14203, 1988
22. Yeoh SI, Baxter RC: Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol 119:465, 1988
23. Suikkari-A, Koivisto VA, Rutanen E, Yki-jarvinen H, Karonen SL, Seppala M: Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266, 1988
24. Conover CA, Lee PDK: Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells. J Clin Endocrinol Metab 70:1062, 1990
25. Young SCJ, Underwood LE, Celniker A, Clemmons DR: Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J Clin Endocrinol Metab 75:603, 1992
26. Baxter RC, Hizuka N, Takano K, Holman SR, Asakawa K: Responses of insulin-like growth factor binding protein-1 (IGFBP-1) and the IGFBP-3 complex to administration of insulin-like growth factor-I. Acta Endocrinol 128:101, 1993
27. Grellier P, Chanson P, Casadevall N, Abboud S, Schaison G: Remission of Polycythemia vera after surigical cure of acromegaly. Ann Intern Med 124:495, 1996
28. DeMellow J, Baxter RC: Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA systhesis in human skin fibroblasts. Biochem Biophys Res Commun 156:199, 1988
29. Knauer DJ, Smith GL: Inhibition of biological activity of multiplication stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 77:7252, 1980
30. Camacho-Hubner C, McCusker RH, Clemmons DR: Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro. J Cell Physiol 148:281, 1991
31. Frost RA, Tseng L: Insulin-like growth factor-binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. J Biol Chem 266:18082, 1991
32. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR: Phosphorylation of insulin-like growth factor (IGF-I)-binding protein-1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc Natl Acad Sci USA 88:7481, 1991
33. Jyung RW, Mustoe TA, Busby WHJ, Clemmons DR: Increased wound breaking strength induced by insulin-like growth factor-I in combination with IGF binding protein-1. Surgery 115:233, 1994